Cargando…

Tumor-Specific miRNA Signatures in Combination with CA19-9 for Liquid Biopsy-Based Detection of PDAC

Pancreatic ductal adenocarcinoma (PDAC) is considered one of the most aggressive malignancies and has high mortality and poor survival rates. Therefore, there is an urgent need to discover non-invasive biomarkers for early detection before PDAC reaches the incurable stage. We hypothesized that liqui...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Min Woo, Koh, Hani, Kim, Jee Ye, Lee, Suji, Lee, Hyojung, Kim, Young, Hwang, Ho Kyoung, Kim, Seung Il
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703833/ https://www.ncbi.nlm.nih.gov/pubmed/34948417 http://dx.doi.org/10.3390/ijms222413621

Ejemplares similares

Multi‐miRNA panel of tumor‐derived extracellular vesicles as promising diagnostic biomarkers of early‐stage breast cancer
por: Kim, Min Woo, et al.
Publicado: (2021)

Upregulated MicroRNA-483-3p is an Early Event in Pancreatic Ductal Adenocarcinoma (PDAC) and as a Powerful Liquid Biopsy Biomarker in PDAC
por: Shao, Huilin, et al.
Publicado: (2021)

Tumor-Stroma Interaction in PDAC as a New Approach for Liquid Biopsy and its Potential Clinical Implications
por: Götze, Julian, et al.
Publicado: (2022)

Circulating miRNAs as Noninvasive Biomarkers for PDAC Diagnosis and Prognosis in Mexico
por: Álvarez-Hilario, Lissuly Guadalupe, et al.
Publicado: (2023)

Advances in methylation analysis of liquid biopsy in early cancer detection of colorectal and lung cancer
por: Kwon, Hyuk-Jung, et al.
Publicado: (2023)

Antibody-mediated blockade for galectin-3 binding protein in tumor secretome abrogates PDAC metastasis
por: Choi, Yeon-Sook, et al.
Publicado: (2022)

A novel methylation signature predicts inferior outcome of patients with PDAC
por: Gu, Minqi, et al.
Publicado: (2021)

Liquid biopsy using extracellular vesicle–derived DNA in lung adenocarcinoma
por: Kim, In Ae, et al.
Publicado: (2020)

Enhancing Lung Cancer Classification through Integration of Liquid Biopsy Multi-Omics Data with Machine Learning Techniques
por: Kwon, Hyuk-Jung, et al.
Publicado: (2023)

Role of Exosomal miRNA in Bladder Cancer: A Promising Liquid Biopsy Biomarker
por: Piao, Xuan-Mei, et al.
Publicado: (2021)

Serum miRNA Profiling for Early PDAC Diagnosis and Prognosis: A Retrospective Study
por: Aita, Ada, et al.
Publicado: (2021)

Autophagy is required for PDAC glutamine metabolism
por: Seo, Ju-Won, et al.
Publicado: (2016)

FKBP5-associated miRNA signature as a putative biomarker for PTSD in recently traumatized individuals
por: Kang, Hyo Jung, et al.
Publicado: (2020)

Serum Dickkopf-1 in Combined with CA 19-9 as a Biomarker of Intrahepatic Cholangiocarcinoma
por: Kim, Si-Young, et al.
Publicado: (2021)

Targeted proteomics identifies liquid-biopsy signatures for extracapsular prostate cancer
por: Kim, Yunee, et al.
Publicado: (2016)

Scaling the immune incline in PDAC
por: Rojas, Luis A., et al.
Publicado: (2021)

miRNA signature associated with outcome of gastric cancer patients following chemotherapy
por: Kim, Chang Hee, et al.
Publicado: (2011)

Practical Utility of Liquid Biopsies for Evaluating Genomic Alterations in Castration-Resistant Prostate Cancer
por: Jeong, Seung-Hwan, et al.
Publicado: (2023)

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening
por: Mensah, Mavis, et al.
Publicado: (2017)

Potential utility of miRNAs for liquid biopsy in breast cancer
por: Liu, Xiangrong, et al.
Publicado: (2022)

Recent Advances in Exosomal miRNA Biosensing for Liquid Biopsy
por: Lin, Bingqian, et al.
Publicado: (2022)

Transverse Space Charge Effect During Bunch Compression in PDAC1 and PDAC2 Compressor Ring
por: Franchetti, Giuliano
Publicado: (2000)

The role of survivin in the progression of pancreatic ductal adenocarcinoma (PDAC) and a novel survivin-targeted therapeutic for PDAC
por: Brown, Matthew, et al.
Publicado: (2020)

Urinary mRNA Signatures as Predictors of Renal Function Decline in Patients With Biopsy-Proven Diabetic Kidney Disease
por: Lee, Yu Ho, et al.
Publicado: (2021)

CD5L as an Extracellular Vesicle-Derived Biomarker for Liquid Biopsy of Lung Cancer
por: Choi, Eun-Sook, et al.
Publicado: (2021)

Extracellular Vesicle-Associated miRNAs as a Biomarker for Lung Cancer in Liquid Biopsy
por: He, Xue, et al.
Publicado: (2021)

Preoperative serum CA19-9 predicts postoperative pancreatic fistula in PDAC patients: retrospective analysis at a single institution
por: Sugita, Hiroki, et al.
Publicado: (2022)

Mutant SF3B1 promotes malignancy in PDAC
por: Simmler, Patrik, et al.
Publicado: (2023)

C/EBPδ Suppresses Motility-Associated Gene Signatures and Reduces PDAC Cell Migration
por: Hartl, Leonie, et al.
Publicado: (2022)

Risk Factors Associated with Discordant Ki-67 Levels between Preoperative Biopsy and Postoperative Surgical Specimens in Breast Cancers
por: Kim, Hyung Sun, et al.
Publicado: (2016)

Clinical Implication of Liquid Biopsy in Colorectal Cancer Patients Treated with Metastasectomy
por: Lee, Soohyeon, et al.
Publicado: (2021)

Liquid Biopsy in Lung Cancer: Clinical Applications of Circulating Biomarkers (CTCs and ctDNA)
por: Lim, Minji, et al.
Publicado: (2018)

SIRT 1 Overexpression is Associated with Metastasis of Pancreatic Ductal Adenocarcinoma (PDAC) and Promotes Migration and Growth of PDAC Cells
por: Li, Siqin, et al.
Publicado: (2016)

Next-Generation Sequencing of Vitreoretinal Lymphoma by Vitreous Liquid Biopsy: Diagnostic Potential and Genotype/Phenotype Correlation
por: Kwak, Jay Jiyong, et al.
Publicado: (2023)

New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies
por: Larrea, Erika, et al.
Publicado: (2016)

Circulating miRNA as a Biomarker in Oral Cancer Liquid Biopsy
por: Roi, Alexandra, et al.
Publicado: (2023)

Guide-Wire Assisted Endobiliary Forceps Biopsy Sampling
por: Kwon, Chang-Il, et al.
Publicado: (2017)

Insights into the Diagnostic Potential of Extracellular Vesicles and Their miRNA Signature from Liquid Biopsy as Early Biomarkers of Diabetic Micro/Macrovascular Complications
por: La Marca, Valeria, et al.
Publicado: (2017)

The role of LOXL2 induced by glucose metabolism-activated NF-κB in maintaining drug resistance through EMT and cancer stemness in gemcitabine-resistant PDAC
por: Lee, Yun Sun, et al.
Publicado: (2023)

CA 19-9 but Not IGF-1/IGFBP-2 Is a Useful Biomarker for Pancreatic Ductal Adenocarcinoma (PDAC) and Chronic Pancreatitis (CP) Differentiation
por: Wlodarczyk, Barbara, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jm1t7psdtduq2kkdv1ug7aljgs